A single nucleotide polymorphism in the matrix metalloproteinase-1 (MMP-1) promoter influences amnion cell MMP-1 expression and risk for preterm premature rupture of the fetal membranes

被引:133
作者
Fujimoto, T
Parry, S
Urbanek, M
Sammel, M
Macones, G
Kuivaniemi, H
Romero, R
Strauss, JF
机构
[1] Univ Penn, Med Ctr, Ctr Res Reprod & Womens Hlth, Philadelphia, PA 19104 USA
[2] Univ Penn, Med Ctr, Dept Genet, Philadelphia, PA 19104 USA
[3] Univ Penn, Med Ctr, Dept Biostat & Clin Epidemiol, Philadelphia, PA 19104 USA
[4] Hutzel Hosp, Perinatol Res Branch, NIH, NICHHD, Detroit, MI 48201 USA
关键词
D O I
10.1074/jbc.M107865200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interstitial collagen gives fetal membranes tensile strength, and membrane rupture has been attributed to collagen degradation. A polymorphism at -1607 in the matrix metalloproteinase-1 (MMP-1) promoter (an insertion of a guanine (G)) creates a core Ets binding site and increases promoter activity. We investigated whether this polymorphism is functionally significant for MMP-1 expression in amnion cells and whether it is associated with preterm premature rupture of the membranes (PPROM). The 2G promoter had >2-fold greater activity than the 1G allele in amnion mesenchymal cells and WISH amnion cells. Phorbol 12-myristate 13-acetate (PMA) increased mesenchymal cell nuclear protein binding with greater affinity to the 2G allele. Induction of MMP-1 mRNA by PMA was significantly greater in cells with a 1G/2G or 2G/2G genotype compared with cells homozygous for the 1G allele. When treated with PMA, the 1G/2G and 2G/2G cells produced greater amounts of MMP-1 protein than 1G/1G cells. A significant association was found between fetal carriage of a 2G allele and PPROM. We conclude that the 2G allele has stronger promoter activity in amnion cells, that it confers increased responsiveness of amnion cells to stimuli that induce MMP-1, and that this polymorphism contributes to the risk of PPROM.
引用
收藏
页码:6296 / 6302
页数:7
相关论文
共 41 条
[1]   A RAPID MICROPREPARATION TECHNIQUE FOR EXTRACTION OF DNA-BINDING PROTEINS FROM LIMITING NUMBERS OF MAMMALIAN-CELLS [J].
ANDREWS, NC ;
FALLER, DV .
NUCLEIC ACIDS RESEARCH, 1991, 19 (09) :2499-2499
[2]   HUMAN MACROPHAGE METALLOELASTASE - GENOMIC ORGANIZATION, CHROMOSOMAL LOCATION, GENE LINKAGE, AND TISSUE-SPECIFIC EXPRESSION [J].
BELAAOUAJ, A ;
SHIPLEY, JM ;
KOBAYASHI, DK ;
ZIMONJIC, DB ;
POPESCU, N ;
SILVERMAN, GA ;
SHAPIRO, SD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (24) :14568-14575
[3]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[4]  
CHURCH RL, 1983, COLLAGEN REL RES, V3, P115
[5]   Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer [J].
Dunleavey, L ;
Beyzade, S ;
Ye, S .
MATRIX BIOLOGY, 2000, 19 (02) :175-177
[6]  
GERHARD DS, 1987, CYTOGENET CELL GENET, V46, P619
[7]  
Guyer B, 1996, PEDIATRICS, V98, P1007
[8]  
JUNG JY, 1990, ANN GENET-PARIS, V33, P21
[9]  
Kanamori Y, 1999, CANCER RES, V59, P4225
[10]   Mapping of the metalloproteinase gene matrilysin (MMP7) to human chromosome 11q21->q22 [J].
Knox, JD ;
Boreham, DR ;
Walker, JA ;
Morrison, DP ;
Matrisian, LM ;
Nagle, RB ;
Bowden, GT .
CYTOGENETICS AND CELL GENETICS, 1996, 72 (2-3) :179-182